AIM: To investigate the expression and pathological factors of Angiopoietin-2 (Ang-2) in primary gastric cancers and adjacent normal tissues. METHODS: The expression of Angiopoietin-2 and VEGF were studied in 72 primary gastric cancers and adjacent normal tissues from the same patients by semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) and immunohistochemistry. RESULTS: Ang-2 was mainly expression in tumor cells. There were significantly difference between expression of Ang-2 in primary gastric cancer and in adjacent normal tissue samples (P=0.003). It was statistically correlation between Ang-2 and VEGF expression in tumors (P=0.0055). With regard to Ang-2 expression in tumors, there were significant difference between early stage and advanced stage (P=0.017), and significant difference between positive vascular involvement and negative vascular involvement (P=0.032). However, there was no significant difference between moderate-poor differential type and high differential type (P=0.908), between positive lymph node metastasis and negative lymph node metastasis (P=0.752), between positive serosal invasion and negative serosal invasion (P=0.764). The cases with expression of Ang-2 were increasing with advanced stage and vascular involvement. CONCLUSION: The results manifested that Angiopoietin-2, coordinated with VEGF, play role in regulating tumor angiogenesis of gastric cancer.
AIM: To investigate the expression and pathological factors of Angiopoietin-2 (Ang-2) in primary gastric cancers and adjacent normal tissues. METHODS: The expression of Angiopoietin-2 and VEGF were studied in 72 primary gastric cancers and adjacent normal tissues from the same patients by semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) and immunohistochemistry. RESULTS:Ang-2 was mainly expression in tumor cells. There were significantly difference between expression of Ang-2 in primary gastric cancer and in adjacent normal tissue samples (P=0.003). It was statistically correlation between Ang-2 and VEGF expression in tumors (P=0.0055). With regard to Ang-2 expression in tumors, there were significant difference between early stage and advanced stage (P=0.017), and significant difference between positive vascular involvement and negative vascular involvement (P=0.032). However, there was no significant difference between moderate-poor differential type and high differential type (P=0.908), between positive lymph node metastasis and negative lymph node metastasis (P=0.752), between positive serosal invasion and negative serosal invasion (P=0.764). The cases with expression of Ang-2 were increasing with advanced stage and vascular involvement. CONCLUSION: The results manifested that Angiopoietin-2, coordinated with VEGF, play role in regulating tumor angiogenesis of gastric cancer.
Authors: T N Sato; Y Tozawa; U Deutsch; K Wolburg-Buchholz; Y Fujiwara; M Gendron-Maguire; T Gridley; H Wolburg; W Risau; Y Qin Journal: Nature Date: 1995-07-06 Impact factor: 49.962
Authors: A Papapetropoulos; G García-Cardeña; T J Dengler; P C Maisonpierre; G D Yancopoulos; W C Sessa Journal: Lab Invest Date: 1999-02 Impact factor: 5.662
Authors: M J Flens; G J Zaman; P van der Valk; M A Izquierdo; A B Schroeijers; G L Scheffer; P van der Groep; M de Haas; C J Meijer; R J Scheper Journal: Am J Pathol Date: 1996-04 Impact factor: 4.307
Authors: K Danza; B Pilato; R Lacalamita; T Addati; F Giotta; A Bruno; A Paradiso; S Tommasi Journal: Eur J Hum Genet Date: 2012-12-12 Impact factor: 4.246
Authors: Venkata R Doppalapudi; Jie Huang; Dingguo Liu; Ping Jin; Bin Liu; Lingna Li; Joel Desharnais; Crystal Hagen; Nancy J Levin; Michael J Shields; Michelle Parish; Robert E Murphy; Joselyn Del Rosario; Bryan D Oates; Jing-Yu Lai; Marla J Matin; Zemeda Ainekulu; Abhijit Bhat; Curt W Bradshaw; Gary Woodnutt; Richard A Lerner; Rodney W Lappe Journal: Proc Natl Acad Sci U S A Date: 2010-12-13 Impact factor: 11.205
Authors: Oscar Vidal; Antonio Soriano-Izquierdo; Manuel Pera; José I Elizalde; Antonio Palacín; Antoni Castells; Josep M Piqué; Alain Volant; Jean P Metges Journal: J Gastrointest Surg Date: 2007-10-31 Impact factor: 3.452